Specialty Drugs and the Broader Cost Surge in Employer Benefits GLP-1s get the headlines, but theyre part of a broader specialty drug trend thats reshaping employer health care cost trends for 2026 and beyond
If you want to explore whether GHRH for fat reduction fits your situation and goals, our team can review your labs, body composition, and treatment options together, so you can decide on a path that helps you feel better, live better, and age better from the inside out
Characteristics of medical professional liability claims against dermatologists: data from 2704 closed claims in a voluntary registry
It is of utmost importance to tailor treatment based on a patients genes, environment and previous medication use, to improve overall outcomes, decrease patients exposure to a drug that might not be effective and be considerate of the financial burden that patients may endure, the researchers wrote.